Masimo (NASDAQ:MASI) Trading 3.2% Higher

Masimo Co. (NASDAQ:MASI)’s share price traded up 3.2% during trading on Friday . The company traded as high as $116.57 and last traded at $115.32. 475,230 shares changed hands during trading, a decline of 26% from the average session volume of 642,672 shares. The stock had previously closed at $111.73.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the company. Needham & Company LLC reiterated a “hold” rating on shares of Masimo in a report on Wednesday, August 7th. Piper Sandler boosted their price objective on Masimo from $160.00 to $165.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Four equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Masimo currently has an average rating of “Moderate Buy” and a consensus price target of $144.67.

Masimo Trading Up 3.4 %

The company has a market cap of $6.14 billion, a P/E ratio of 76.01 and a beta of 0.98. The business has a fifty day moving average price of $114.82 and a 200-day moving average price of $125.08. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.09. The business had revenue of $496.30 million during the quarter, compared to analysts’ expectations of $493.92 million. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.62 earnings per share. On average, analysts forecast that Masimo Co. will post 3.87 earnings per share for the current year.

Institutional Investors Weigh In On Masimo

Institutional investors have recently made changes to their positions in the stock. Wells Fargo & Company MN boosted its stake in shares of Masimo by 282.0% in the fourth quarter. Wells Fargo & Company MN now owns 116,712 shares of the medical equipment provider’s stock valued at $13,680,000 after buying an additional 86,162 shares during the period. State Board of Administration of Florida Retirement System lifted its stake in Masimo by 11.6% during the first quarter. State Board of Administration of Florida Retirement System now owns 54,839 shares of the medical equipment provider’s stock worth $8,053,000 after purchasing an additional 5,688 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in Masimo by 32.1% during the first quarter. Advisors Asset Management Inc. now owns 9,009 shares of the medical equipment provider’s stock worth $1,323,000 after purchasing an additional 2,187 shares during the last quarter. Vanguard Group Inc. lifted its stake in Masimo by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 4,781,343 shares of the medical equipment provider’s stock worth $560,421,000 after purchasing an additional 26,473 shares during the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Masimo by 5.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 301,488 shares of the medical equipment provider’s stock worth $35,339,000 after purchasing an additional 16,042 shares during the last quarter. 85.96% of the stock is currently owned by institutional investors.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.